Hematopoietic stem cell transplantation in severe congenital neutropenia

Pediatric Blood and Cancer

Volumn 56, Issue 3, 2011, Pages 444-451

  Carlsson, G ^a   Winiarski, J ^a   Ljungman, P ^a   Ringden O ^a   Mattsson, J ^a   Nordenskjold M ^a   Touw, I ^b   Henter, J I ^a   Palmblad, J ^a   Fadeel, B ^c   Hagglund H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chimerism; Hematopoietic stem cell transplantation; Myelodysplastic syndrome leukemia; Severe congenital neutropenia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MELPHALAN; METHOTREXATE; PREDNISOLONE; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; TREOSULFAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR LYMPHOCYTE INFUSION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENE MUTATION; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; LOW DRUG DOSE; MALE; MUTATIONAL ANALYSIS; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD; SEVERE CONGENITAL NEUTROPENIA; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78651094965     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22836     Document Type: Article

References (43)

1. Carlsson G, Andersson M, Pütsep K, et al. Kostmann syndrome or infantile genetic agranulocytosis, part one: Celebrating 50 years of clinical and basic research on severe congenital neutropenia. Acta Paediatr 2006; 95: 1526-1532.
2. Carlsson G, Melin M, Dahl N, et al. Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia. Acta Paediatr 2007; 96: 813-819.
3. Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol 2006; 43: 189-195.
4. Kostmann R. Infantile genetic agranulocytosis. A new recessive lethal disease in man. Acta Paediatr 1956; 45: 1-78.
5. Kostmann R. Infantile genetic agranulocytosis. A review with presentation of ten new cases. Acta Paediatr 1975; 64: 362-368.
6. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96: 2317-2322.
7. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007; 39: 86-92.
8. Person RE, Li FQ, Duan Z, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003; 34: 308-312.
9. Storb R, Thomas ED. Allogeneic bone marrow transplantation. Immunol Rev 1983; 71: 77-102.
10. Ringdén O, Remberger M, Svenberg P, et al. Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem-cell transplantation for treatment of non-malignant diseases. Bone Marrow Transplant 2007; 39: 383-388.
11. Ringdén O, Remberger M, Svahn B-M, et al. Allogeneic hematopoietic stem cell transplantation for inherited disorders: Experience in a single-center. Transplantation 2006; 81: 718-725.
12. Rosenberg PS, Alter BP, Bolyard AA, et al. Severe Chronic Neutropenia International Registry. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006; 107: 4628-4635.
13. Rosenberg PS, Alter BP, Link DC, et al. Neutrophil elastase mutations and risk of leukemia in severe congenital neutropenia. Br J Haematol 2008; 140: 210-213.
14. Zeidler C, Boxer L, Dale DC, et al. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 2000; 109: 490-495.
15. Freedman MH, Bonilla MA, Fier C, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000; 96: 429-436.
16. Zeidler C, Germeshausen M, Klein C, Welte K. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2009; 144: 459-467.
17. Choi SW, Boxer LA, Pulsipher MA, et al. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation. Bone Marrow Transplant 2005; 35: 473-477.
18. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: Treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72: 82-93.
19. Carlsson G, Aprikyan AA, Ericson KG, et al. Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden. Haematologica 2006; 91: 589-595.
20. Ringdén O, Ruutu T, Remberger M, et al. A randomized trial comparing busulphan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia. A report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 2723-2730.
21. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic disease. Blood 1998; 91: 756-763.
22. Storb R, Martin P, Deeg HJ, et al. Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia. Blood 1992; 79: 3091-3092.
23. Carlens S, Aschan J, Remberger M, et al. Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukemia. Bone Marrow Transplant 1999; 24: 629-635.
24. Ringdén O, Okas M, Uhlin M, et al. Unrelated cord blood and mismatched unrelated donor transplants, two alternatives in patients who lack an HLA-identical donor. Bone Marrow Transplant 2008; 42: 643-648.
25. Carlsson G, Van't Hooft I, Melin M, et al. Central nervous system involvement in severe congenital neutropenia: Neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med 2008; 264: 388-400.
26. Melin M, Entesarian M, Carlsson G, et al. Assignment of the gene locus for severe congenital neutropenia to chromosome 1q22 in the original Kostmann family from Northern Sweden. Biochem Biophys Res Commun 2007; 353: 571-575.
27. Rappeport JM, Parkman R, Newburger P, et al. Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. Am J Med 1980; 68: 605-609.
28. Zeidler C, Welte K, Barak Y, et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95: 1195-1198.
29. Ferry C, Ouachée M, Leblanc T, et al. Hematopoietic stem cell transplantation in severe congenital neutropenia: Experience of the French SCN register. Bone Marrow Transplant 2005; 35: 45-50.
30. Ringdén O, Okas M, Uhlin M, et al. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Bone Marrow Transplant 2008; 42: 643-648.
31. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285.
32. Fukano R, Nagatoshi Y, Shinkoda Y, et al. Unrelated bone marrow transplantation using a reduced-intensity conditioning regimen for the treatment of Kostmann syndrome. Bone Marrow Transplant 2006; 38: 635-636.
33. Gilman PA, Jackson DP, Guild HG. Congenital agranulocytosis: Prolonged survival and terminal acute leukemia. Blood 1970; 36: 576-585.
34. McLemore ML, Poursine-Laurent J, Link DC. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. J Clin Invest 1998; 102: 483-492.
35. Hermans MH, Antonissen C, Ward AC, et al. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med 1999; 189: 683-692.
36. Toyoda H, Azuma E, Hori H, et al. Successful unrelated BMT in a patient with Kostmann syndrome complicated by pre-transplant pulmonary 'bacterial' abscesses. Bone Marrow Transplant 2001; 28: 413-415.
37. Dallorso S, Manzitti C, Dodero P, et al. Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of Kostmann syndrome and long-lasting invasive pulmonary mycosis. Eur J Haematol 2003; 70: 322-325.
38. Mino E, Kobayashi R, Yoshida M, et al. Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia. Bone Marrow Transplant 2004; 33: 969-971.
39. Nakazawa Y, Sakashita K, Kinoshita M, et al. Successful unrelated cord blood transplantation using a reduced-intensity conditioning regimen in a 6-month-old infant with congenital neutropenia complicated by severe pneumonia. Int J Hematol 2004; 80: 287-290.
40. Cojean N, Blondet C, Marcellin L, et al. Successful stem cell transplantation in an infant with severe congenital neutropenia complicated by pretransplant inflammatory pseudotumor of the liver. Bone Marrow Transplant 2006; 38: 641-643.
41. Thachil J, Caswell M, Bolton-Maggs PH, et al. Non-myeloablative transplantation for severe congenital neutropenia. Pediatr Blood Cancer 2008; 50: 920-921.
42. Markel MK, Haut PR, Renbarger JA, et al. Unrelated cord blood transplantation for severe congenital neutropenia: Report of two cases with very different transplant courses. Pediatr Transplant 2008; 12: 896-901.
43. Yesilipek MA, Tezcan G, Germeshausen M, et al. Unrelated cord blood transplantation in children with severe congenital neutropenia. Pediatr Transplant 2009; 13: 777-781.